17 January 2023 - - US-based biotechnology company Celularity Inc. (NASDAQ: CELU) and import, export and trading company CH Trading Group LLC have entered into an exclusive distribution agreement with the Tamer Group, the companies said.

The Tamer Group, a leading Middle East healthcare distribution company, will be the exclusive distributor for Celularity's branded regenerative biomaterial products in Saudi Arabia.

According to the most recent analysis by Emergent Research, the worldwide regenerative medicine market was USD 9.80bn in 2021, and is anticipated to grow at a revenue compounded annual growth rate of 15.9% to reach USD 37.10bn in 2030.

Through the agreement, CH Trading Group will distribute to more than 100 countries that are members of or associated with the following intergovernmental organizations:

The Organization of Islamic Cooperation, which has 57 member countries on four continents;
The Gulf Cooperation Council, comprised of Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates; and
The African Union, which has 55 member countries.

Celularity's suite of biomaterial products include:

Biovance, a decellularized, dehydrated human amniotic membrane derived from the placenta of a healthy, full-term pregnancy.

Biovance is an intact, extracellular matrix structure that is indicated for use in the United States as a natural scaffold to support the body's wound healing process.

Biovance 3L and Biovance 3L Ocular, tri-layer human amniotic membrane products focused on the surgical and ocular markets and available in both sheet and disk form.

Interfyl, a human connective tissue matrix derived from the placenta of a healthy, full-term pregnancy.

It is indicated for use in the United States to replace or supplement damaged or inadequate integumental tissue resulting from wounds, trauma, or surgery.

CentaFlex, a decellularized human placental matrix derived from the umbilical cord that is indicated for use in the United States as a surgical covering, wrap or barrier to protect and support the repair of damaged tissue.

It is anticipated that these biomaterial products are to become available in Saudi Arabia in 2023 following receipt of approval from the Saudi Food and Drug Authority.

Tamer is expected to be Celularity's and CH Group's local strategic partner for Celularity's Lifebank business model for placenta and cord blood banking, as well as for a new Serum Banking business and other potential research and development collaborations.

Celularity Inc. (NASDAQ: CELU) headquartered in Florham Park, N.J., is a US-based biotechnology company leading the next evolution in cellular medicine by developing allogeneic cryopreserved off-the-shelf placental-derived cell therapies, including therapeutic programs using unmodified natural killer cells, genetically modified NK cells, T-cells engineered with a CAR (CAR-T cells), and mesenchymal-like adherent stromal cells (MLASCs).

These therapeutic programs target indications in cancer, infectious and degenerative diseases.

In addition, Celularity develops and manufactures innovative biomaterials also derived from the postpartum placenta.

Celularity believes that by harnessing the placenta's unique biology and ready availability, it can develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.

CH Trading Group LLC is part of the CH Group family of companies.

CH Group constitutes a diversified conglomerate targeting eight economic "Sectors": healthcare, pharmaceuticals, food, finance, cosmetics, tourism, fashion, media/entertainment.

Spanning a variety of multi-national products, services and solutions, its world mission involves connecting, developing and promoting, from Local to Global and throughout the world, all aspects of a wholesome, healthy and productive lifestyle.

CH Trading focuses on international import/export and trade, prioritizing the countries of the Organization of Islamic Cooperation, as well as the Middle East and North Africa and Gulf Cooperation Council Regions.

It has responded to worldwide demands for identifying and securing supply chains by introducing innovative products, including from the US, and developing a robust distribution network for goods.

Tamer Group is a healthcare, beauty care, prestige products, fast-moving consumer goods, and third-party logistics company that caters to the Saudi and Middle Eastern communities' rising demands.

Importing, distribution, promotion, marketing, and manufacturing are the group's main businesses.

Tamer Group, based in Jeddah, Saudi Arabia, provides services to many companies through a variety of agreements, partnerships, and joint ventures. Because of its distinctive approach to business, service, and customer portfolio, the company has established a special position in the Saudi market.